Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krishna Bajjuri

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Chemical Information and Modeling|May 6, 2022
Indexing Ultrafast Shape-Based Descriptors in MongoDB to Identify TLR4 Pathway AgonistsValery R Polyakov, Vadim Alexandrov, Andreas Maderna, et al.
Journal of Chemical Information and Modeling|May 1, 2023
Building Machine Learning Small Molecule Melting Points and Solubility Models Using CCDC Melting Points DatasetXiangwei Zhu, Valery R Polyakov, Krishna Bajjuri, et al.
Molecular Cancer Therapeutics|April 28, 2025
The anti-FRα antibody-drug conjugate luveltamab tazevibulin demonstrates efficacy in non-small cell lung cancer preclinical models and induces immunogenic cell deathRobert Yuan, Andrew McGeehan, Sihong Zhou, et al.
Molecular Cancer Therapeutics|December 2, 2022
Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial CancersXiaofan Li, Sihong Zhou, Cristina L Abrahams, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Chemical Information and Modeling|May 6, 2022
Indexing Ultrafast Shape-Based Descriptors in MongoDB to Identify TLR4 Pathway AgonistsValery R Polyakov, Vadim Alexandrov, Andreas Maderna, et al.
Journal of Chemical Information and Modeling|May 1, 2023
Building Machine Learning Small Molecule Melting Points and Solubility Models Using CCDC Melting Points DatasetXiangwei Zhu, Valery R Polyakov, Krishna Bajjuri, et al.
Molecular Cancer Therapeutics|April 28, 2025
The anti-FRα antibody-drug conjugate luveltamab tazevibulin demonstrates efficacy in non-small cell lung cancer preclinical models and induces immunogenic cell deathRobert Yuan, Andrew McGeehan, Sihong Zhou, et al.
Molecular Cancer Therapeutics|December 2, 2022
Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial CancersXiaofan Li, Sihong Zhou, Cristina L Abrahams, et al.
Pageof 1